Macular corneal dystrophy: immunochemical characterization using monoclonal antibodies

Area of Science:

• Ophthalmology
• Cell Biology
• Biochemistry

Background:

• Macular corneal dystrophy (MCD) is an inherited eye condition causing corneal opacities due to abnormal stromal deposits.
• Understanding the molecular basis of these deposits is crucial for diagnosing and potentially treating MCD.

Purpose of the Study:

• To identify and characterize the specific antigens present in the abnormal stromal deposits of macular corneal dystrophy.
• To differentiate these antigens from known cytoskeletal proteins like vimentin.

Main Methods:

• Screening of monoclonal antibodies against corneal fibroblast antigens.
• Indirect peroxidase-conjugated immunostaining on corneal tissues.
• Immunofluorescent staining and immunoelectron microscopy on cultured corneal fibroblasts.
• Immunoblotting analysis of cytoskeletal proteins.

Main Results:

• A monoclonal antibody (8F1-3) strongly reacted with abnormal deposits in MCD corneas.
• The antigen recognized by 8F1-3 showed increased concentration in MCD corneal cells compared to normal cells.
• Immunostaining revealed a filamentous pattern similar to vimentin, but the antigen was not vimentin.
• Immunoblotting identified two distinct polypeptides (Mr 48,000 and 45,000) recognized by 8F1-3, differing from vimentin (Mr 58,000).

Conclusions:

• A novel intermediate filament-associated antigen, distinct from vimentin, is significantly elevated in macular corneal dystrophy.
• This antigen represents a potential diagnostic marker and therapeutic target for MCD.